Myeloma 2016: Panel discussion on the application of genomics studies
Leif Bergsagel et al.
A free market and data-driven approach to solve the issue of drug cost
Using models to predict progression in follicular lymphoma
Patient and physician perceptions on the symptomatic and economic burden of MPNs
What does a physician need to consider when treating relapsed or refractory myeloma?